The Centers for Disease Control and Prevention’s vaccine advisory committee plans to hold an emergency meeting this month to discuss the higher than expected reports of heart inflammation in young males following a second dose of the Pfizer and Moderna COVID-19 vaccines.
The June 18 meeting will address the conditions that are very infrequent and have not been directly linked to the vaccines, the agency announced on June 10.